Taking a Closer Look at 4-Amino-N-((2R,3S)-3-Amino-2-Hydroxy-4-Phenylbutyl)-N-Isobutylbenzenesulfonamide (161A)

Unlocking the Potential of a Unique Chemical Scaffold

Modern research in the field of medicinal chemistry always seeks out new molecules that combine high potential with specific selectivity. 4-Amino-N-((2R,3S)-3-Amino-2-Hydroxy-4-Phenylbutyl)-N-Isobutylbenzenesulfonamide, commonly referred to as 161A, has generated sustained interest thanks to a distinctive arrangement of functional groups and stereochemistry that sets it apart from everyday chemical products. Reading firsthand accounts from researchers, one theme always stands out: the right molecule unlocks entirely new avenues in bench research and pilot studies, while the wrong match slows progress. That is why compounds like 161A matter to the community.

161A stands apart from typical benzenesulfonamide derivatives due to its sophisticated construction. The presence of both amino and hydroxy functional groups on a chiral butyl chain, paired with a phenyl substitution, opens up unique chemical and biological interactions. This molecule doesn't simply serve as another scaffold in a library—instead, it delivers a convergence of physicochemical properties not often seen in the ordinary chemical toolkit.

Structural Features Drive Function

Direct experience in laboratory design has taught me the value of stereochemistry. With 161A, the (2R,3S)-configuration gives it greater specificity in binding studies, letting researchers pinpoint the interactions that truly matter for their targets. The difference may not seem apparent at first glance, but small changes in chirality sometimes spell the difference between a hit and a lead compound, or a non-starter and a breakthrough. Here, the combination of the two chiral centers, plus the amino and hydroxy groups, provides flexibility and reactivity that enable a range of downstream applications in synthesis and screening.

A feature many appreciate is the dual amino substitutions, which confer extra hydrogen bonding potential—useful in medicinal chemistry screens focused on protein-ligand engagement. The hydroxy substituent on the chiral butyl backbone adds solubility in polar solvents, a practical edge in early-stage assays or bioavailability trials. From conversations with colleagues, nothing grinds a research program to a halt like an insoluble compound gingerly floating at the top of a test well. 161A dodges this pitfall through careful structural design.

What Separates 161A?

Chemists will tell you, and I have seen it repeatedly, that minor structural tweaks can produce dramatic effects in the lab. 161A doesn't resemble the bulk simpler benzenesulfonamides that populate most chemical repositories. Many standard products only modify the sulfonamide backbone with smaller, less complex aliphatic groups, which limits application and diversity. Here, the isobutyl group on the sulfonamide nitrogen increases lipophilic character without sacrificing solubility, while the chiral butyl chain introduces a framework often lacking from generic analogues.

The phenyl ring attached to the butyl group serves more than a decorative purpose. In my work, aromatic moieties routinely improve target binding, engage in π-π stacking, and enable selectivity measurements in protein targets, such as kinases or enzymes with aromatic-rich binding clefts. These are not idle hopes; years of structure-activity relationship studies confirm that aromatic portions help drive potency where aliphatic chains cannot.

What sets 161A apart also lies in the specific arrangement of its functional groups: not just the presence, but the spatial orientation, which influences how it fits into biological macromolecules. Search the catalogues of common building blocks, and often you find abundant choice of simpler sulfonamides or amino alcohols, but relatively few options combine them with careful stereocontrol and appended aromatic groups. This refinement brings something fresh to drug discovery pipelines hungry for new shapes and interaction profiles.

Usage in Modern Research

In practice, 161A finds a home in platforms where chemical diversity counts. Screening programs hunting for new modulators or inhibitors reach first for molecules offering unique fingerprints and interaction points. Journal articles and research notebooks line up with examples of sulfonamides acting as key fragments in lead generation, particularly for enzyme inhibition, given their ability to mimic natural substrates or cofactors.

During my time in the lab, I saw the struggle of optimizing lead compounds. Modestly functionalized sulfonamides serve as good handles, yet lack punch beyond simple hydrogen bonding. A molecule like 161A, equipped with both basic and polar groups, changes the game—one section can engage deeply in the active site of an enzyme, while another portion can interact with adjacent pockets. The balance of hydrophobic and hydrophilic characters increases target specificity and solubility, which no medicinal chemist ignores.

Researchers also value products like 161A for their readiness to slot into standard synthetic sequences. The benzenesulfonamide core remains sturdy under a wide range of reaction conditions, while the chiral side chain offers handles for further derivatization. Modifying the amino or hydroxy groups—common tricks in combinatorial libraries—adds diversity without rebuilding the molecule from scratch. This versatility saves precious time and resources, a clear win for anyone managing a research timeline with tight grant deadlines.

Distinctive Value in Biological Assays

Real-world feedback comes straight from scientists running assays: finding hits that stand out from the noisy background of false positives requires thoughtful selection at the very beginning. 161A’s structure brings necessary complexity without overwhelming synthetic accessibility, letting research teams probe protein active sites and explore novel binding interactions with more confidence.

Protein crystallization studies, for example, often hinge on having molecules that display both rigidity and flexibility in the same structure. 161A’s backbone resists hydrolysis, an asset in protracted incubations, yet presents enough conformational pliability to slot into snug pockets. The presence of chiral centers helps crystallographers resolve electron density with clarity, as asymmetric units often match up more reliably with well-defined ligands. This improves the odds of generating a real, actionable molecular portrait. Success stories in structural biology often owe their existence to such careful scaffold choices.

A peek inside medicinal chemistry discussions highlights the growing need for compounds with multiple points of contact—so-called bidentate or tridentate interactions. Here, 161A’s triad of key groups (two amines, one hydroxy) creates a canvas for designing high-affinity molecules. Data from kinetic binding assays often show increases in residence time and on-target effects when such architectures are used, which translates to better drug candidates in downstream studies.

The Importance of Stereochemistry and Functional Group Placement

One lesson drummed into every chemist is this: stereochemistry is not icing on the cake, it is half the recipe. Compounds such as 161A embody this principle. Two chiral centers—not randomly placed, but precisely arranged—govern everything from the way the molecule turns in space to its orientational fit inside protein structures. Such attention to spatial details pays dividends in selectivity and off-target screens, which routinely suffer from compounds lacking stereodefinition.

Distinct from many generic sulfonamides that offer single functionalization and minimal stereocomplexity, 161A provides a model with tailored three-dimensionality. This isn't about chasing complexity for its own sake. Rather, in practice, more defined geometry means fewer dead-ends during SAR expansion. Synthetic chemists appreciate scaffolds allowing reliable access to both enantiomers or diastereomers without convoluted purification steps. 161A’s mature construction helps sidestep common bottlenecks in chiral separation or post-synthetic modification, letting teams focus on biology rather than bench logistics.

Medicinal chemists also know that careful functional group placement—like the para-positioning of the phenyl and butyl substituents here—lets each moiety contribute independently to binding and activity. The arrangement in 161A offers options for further chemical tweaks: a reactive hydroxy allows for straightforward derivatization (like esterification), while protecting group strategies on either amino functionality expand the chemist’s menu. These features convert what starts as a promising compound into a central player across multiple series of analogues.

Applications in Drug Discovery and Beyond

Within early-stage drug discovery, 161A jumps out as a go-to scaffold for those tackling tough biological problems: enzyme inhibition, GPCR modulation, and even fragment-based screening programs. Its combination of polarity, lipophilicity, and aromatic content makes it the rare small molecule capable of straddling several chemical spaces. In fragment-based drugs in particular, molecules like 161A serve as beachheads for diversity expansion—letting researchers grow compounds in several directions, guided by protein co-crystal structures or docking data.

Beyond classical pharmaceuticals, fields like agrochemicals and material sciences have picked up on the versatility that this compound brings. For agricultural research, benzenesulfonamides show activity as enzyme inhibitors, and 161A’s tailored structure increases the odds of discovering new modes of pest or weed control. In my experience with collaboration between departments, having a common scaffold that bridges the gap between biological and synthetic needs streamlines communication and solves organizational headaches.

Target validation studies depend upon analogues with slight modifications, and 161A’s core keeps synthetic chemistry accessible without daunting barriers to scale-up. Researchers can produce enough of this compound—and its derivatives—for wide-ranging bioassays and field trials, bypassing the scale issues that plague molecules loaded with exotic elements or fragile bonds. The robust framework of 161A holds up during process development, lets users create intermediates for pilot studies, and stands out for its repeatability.

Practical Advantages for the Research Bench

Working day-to-day on a research bench confronts a scientist with mundane realities: handling time, stability under storage, and ease of purification. 161A has become a favorite in several labs across fields thanks in part to its straightforward physical properties—middle-of-the-road melting points, manageable hygroscopicity, and compatibility with standard analytical methods such as NMR, LC-MS, and HPLC. Situations arise in which a bit more polarity or additional aromatic character would clog the column or foul a detector. With 161A, careful engineering solves those problems before they ever reach the bench.

In routine workups, the presence of both amino and hydroxy groups allows chemists to quickly tag, label, or derivatize the molecule for in vitro assays or fluorescent tracking. Colleagues running ADMET profiles value such features, since samples must often be conjugated or functionalized on short notice. This flexibility continues to pay off once compounds move from bench to animal studies, where metabolic stability matters just as much as initial potency.

I’ve watched teams compare analogues and repeatedly come back to scaffolds offering just enough functionality without excess baggage. 161A performs well in this context. It delivers targeted reactivity without producing bystander signals or background noise that can compromise control samples. Its moderate molecular weight keeps it in play for both fragment-based screens and classical medicinal chemistry campaigns, covering more ground than “bulkier” alternatives bloated by unnecessary side chains or heavy heteroatoms.

How 161A Responds to Tougher Research Demands

Today's research climate constantly asks for more detail, more selectivity, and better leads. Raw screening compounds need to be tough enough to stand up to a researcher’s rough handling and analytical scrutiny, but nimble enough for modification on demand. In this context, 161A helps cut through the noise. Peers regularly emphasize how its dual chiral centers and array of interactive functionalities provide more than just another number on a catalog page—they empower research to move faster, with fewer “dead ends.”

This molecule’s resilience across a range of solvents and pH makes it more than just a niche player. Experienced formulators prize stable solubility profiles and consistency under variable conditions, both in vitro and during downstream scale-up. By comparison, less mature benzenesulfonamide analogues either degrade or refuse to dissolve in crucial assay buffers, halting progress at just the wrong moment. 161A manages to skirt these pitfalls, keeping projects alive even when experimental conditions turn challenging.

Where other sulfonamide derivatives show limited potential due to narrow scope or poor chemical reactivity, the design of 161A gives options. Chemists exploit the amines for reductive amination, acylation, or bioconjugation; use the hydroxy group for activation or labeling; and rely on the sturdy benzenesulfonamide core for long-term assay stability. This arsenal of modifications hasn’t simply come from catalog wishlists—it reflects feedback from the lab, where flexible, multi-role compounds hold a clear edge.

Solving Real Research Problems

Scientists never lack for clever ideas, but translating those ideas into reproducible results depends on real, tangible tools like 161A. Over years of troubleshooting, nothing smooths progress like having molecules that answer “yes” to multiple demands: reactivity, selectivity, stability, and ease of handling. 161A addresses common problems such as poor solubility, synthetic intractability, or limited functionalization, which sideline a wide swath of less carefully crafted molecules.

Take the challenge of rapidly assembling focused compound libraries. Many research groups, mine included, meet resistance at the scale-up phase because traditional sulfonamide derivatives balk at multistep diversification or degrade under basic conditions. 161A goes further by serving as a springboard for a family of analogues—each step leverages the available amino and hydroxy groups for iterative modification, building complexity without throwing away the original scaffold.

Pharmaceutical discovery processes nowadays include early ADME profiling. The hydroxy and amino functions on 161A strike a balance between polarity and permeability, making it easier to design analogues that clear intestinal barriers or escape efflux. Colleagues specializing in pharmacokinetics document improved uptake and metabolic profiles with such scaffolds, sidestepping the all-too-common graveyard of “flat” molecules that go nowhere in vivo. The compound’s ease of handling also works in its favor—not requiring elaborate storage protocols or rare solvents, it becomes a utility player in programs both small and large.

Looking Beyond the Ordinary: 161A’s Real-World Impact

New chemical matter isn’t just about the next publication—it’s about clearing out bottlenecks and reshaping what’s possible. From my own perspective, the field advances one thoughtfully made molecule at a time. 161A’s design bears the handprints of real laboratory experience, fusing aromatic interaction potential with both basic and polar functionality to fill gaps left by standard offerings. Search catalogues or ask fellow researchers, and you’ll hear the refrain: compounds combining toolkit flexibility and synthetic manageability deliver the clearest path from idea to impact.

Research often rewards those prepared with the right materials. By bringing together well-chosen groups in a chiral, functionalized core, 161A unlocks options for targeted screening, SAR exploration, and downstream development projects. As new synthetic methodologies emerge, adaptable scaffolds like this one pave the way for greener, more efficient processes and smarter drug discovery campaigns. In an era prioritizing environmental responsibility, using compounds with robust, well-understood chemistry also reduces waste and improves reproducibility—benefits every scientist can appreciate.

In the wider context of innovation, building a new generation of chemical tools means valuing molecules that pull their weight across the entire research pipeline. 161A doesn’t just hand over one advantage—its structure figures into many problem-solving scenarios, whether expanding library diversity, discovering leads for stubborn targets, or sidestepping legacy issues with older chemical classes. Feedback from continuous use points to consistent rewards: more robust data, more confident SAR conclusions, and a smoother path through the maze of early development.

Charting a Smarter Path with Advanced Chemotypes

Keeping pace with the demands of modern scientific discovery means reaching for molecules that deliver more than just adequate performance. The innovation embedded in 161A stems from hard-won laboratory lessons and real-world troubleshooting. At a time when every group wants to maximize throughput and minimize dead-ends, choosing compounds engineered for both flexibility and specificity becomes all the more critical.

Compounds with multiple functional groups—balanced to avoid liabilities yet reactive enough for custom modification—form the backbone of success in both commercial and academic settings. The fine control over stereochemistry and the strategic use of both aromatic and aliphatic elements enable teams to go from blank slate to promising lead without sacrificing efficiency. 161A exemplifies the benefits of such clarity in design, constantly offering new paths forward in research where lesser alternatives would stall.

Experience continues to reinforce the principle that trusted, well-characterized chemical tools power breakthrough insights. 161A stands as a reminder that the gap between concept and application shrinks when the right materials meet the right minds. Thorough exploration of this compound’s real-world performance will shape further advances—not just in chemistry, but also in the many scientific fields it touches. In a discipline always on the move, the value of such a well-designed scaffold continues to build, bridging the needs of today’s researchers with tomorrow’s innovations.